A 52-week, multinational, open-label, parallel-group, noninferiority, treat-to-target trial comparing insulin detemir with insulin glargine in a basal-bolus regimen with mealtime insulin aspart in patients with type 2 diabetes

Published 2008 View Full Article

Authors

Keywords

Journal

CLINICAL THERAPEUTICS

Volume 30, Issue 11, Pages 1976-1987

Publisher

Elsevier BV

Online

2008-12-25

DOI

10.1016/j.clinthera.2008.11.001

Ask authors/readers for more resources

Find the ideal target journal for your manuscript

Explore over 38,000 international journals covering a vast array of academic fields.

Become a Peeref-certified reviewer

The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.

Get Started

CLINICAL THERAPEUTICS

Ask authors/readers for more resources

Protocol

Reagent

Reprint

Find the ideal target journal for your manuscript

Become a Peeref-certified reviewer